These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10461309

  • 1. Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Varriale P, Sedighi A, Mirzaietehrane M.
    Pacing Clin Electrophysiol; 1999 Aug; 22(8):1267-9. PubMed ID: 10461309
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiological effects of ibutilide in patients with accessory pathways.
    Glatter KA, Dorostkar PC, Yang Y, Lee RJ, Van Hare GF, Keung E, Modin G, Scheinman MM.
    Circulation; 2001 Oct 16; 104(16):1933-9. PubMed ID: 11602497
    [Abstract] [Full Text] [Related]

  • 3. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: role of pulmonary veins.
    Derejko P, Szumowski LJ, Sanders P, Krupa W, Bodalski R, Orczykowski M, Urbanek P, Zakrzewska J, Lim HS, Lau DH, Kuśnierz J, Walczak F.
    J Cardiovasc Electrophysiol; 2012 Mar 16; 23(3):280-6. PubMed ID: 22035173
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA, Stambler BS, Wood MA, Sager PT, Wesley RC, Meissner MC, Zoble RG, Wakefield LK, Perry KT, Vanderlugt JT.
    J Am Coll Cardiol; 1996 Jul 16; 28(1):130-6. PubMed ID: 8752805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome.
    Krahn AD, Klein GJ, Yee R.
    Pacing Clin Electrophysiol; 2001 Aug 16; 24(8 Pt 1):1258-60. PubMed ID: 11523612
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA, Clemo HF, Stambler BS, Wood MA, VanderLugt JT.
    Am J Cardiol; 1996 Oct 17; 78(8A):42-5. PubMed ID: 8903275
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
    Waspe LE, Brodman R, Kim SG, Fisher JD.
    Am Heart J; 1986 Dec 17; 112(6):1141-52. PubMed ID: 3788760
    [Abstract] [Full Text] [Related]

  • 11. Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation.
    Singh SM, D'Avila A, Kim SJ, Houghtaling C, Dukkipati SR, Reddy VY.
    J Cardiovasc Electrophysiol; 2010 Jun 01; 21(6):608-16. PubMed ID: 20039991
    [Abstract] [Full Text] [Related]

  • 12. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
    Centurión OA, Shimizu A, Isomoto S, Konoe A.
    Europace; 2008 Mar 20; 10(3):294-302. PubMed ID: 18308751
    [Abstract] [Full Text] [Related]

  • 14. Ibutilide increases the variability and complexity of atrial fibrillation electrograms: antiarrhythmic insights using signal analyses.
    Biviano AB, Ciaccio EJ, Gabelman T, Whang W, Garan H.
    Pacing Clin Electrophysiol; 2013 Oct 20; 36(10):1228-35. PubMed ID: 23875908
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
    Stambler BS, Wood MA, Ellenbogen KA.
    Circulation; 1997 Dec 16; 96(12):4298-306. PubMed ID: 9416896
    [Abstract] [Full Text] [Related]

  • 16. Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.
    Sasaki N, Watanabe I, Kogawa R, Sonoda K, Takahashi K, Okumura Y, Ohkubo K, Nakai T, Hirayama A.
    Int Heart J; 2014 Dec 16; 55(3):244-8. PubMed ID: 24806377
    [Abstract] [Full Text] [Related]

  • 17. MY APPROACH to the Athlete With Wolff-Parkinson-White Syndrome (WPW).
    Baggish AL, Shah AB.
    Trends Cardiovasc Med; 2018 Feb 16; 28(2):154-155. PubMed ID: 29032933
    [No Abstract] [Full Text] [Related]

  • 18. Atrial Fibrillation in a 35-Year-Old Man with Wolff-Parkinson-White Syndrome.
    Hudzik B, Szkodzinski J, Polonski L.
    Tex Heart Inst J; 2015 Oct 16; 42(5):502-3. PubMed ID: 26504453
    [No Abstract] [Full Text] [Related]

  • 19. The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome.
    Ren J, Yang Y, Zhu J, Wu S, Wang J, Zhang H, Shao X.
    Pacing Clin Electrophysiol; 2021 Jan 16; 44(1):35-43. PubMed ID: 33118640
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
    Milstein S, Klein GJ, Rattes MF, Sharma AD, Yee R.
    J Am Coll Cardiol; 1987 Dec 16; 10(6):1244-8. PubMed ID: 3680792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.